The elevated plasma FLT4, also named Vascular Endothelial Growth Factor Receptor 3 (VEGFR3) in the late stage of CRC may be associated with VEGF-mediated lymphangiogenesis and angiogenesis. This evidence concerns the gene FLT4 and colorectal carcinoma.